Freedman Financial Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,751
Closed -$485K 222
2022
Q1
$485K Buy
2,751
+45
+2% +$7.66K 0.33% 38
2021
Q4
$463K Sell
2,706
-113
-4% -$18.5K 0.32% 36
2021
Q3
$455K Buy
2,819
+116
+4% +$19.8K 0.33% 35
2021
Q2
$445K Buy
2,703
+32
+1% +$5.3K 0.34% 36
2021
Q1
$439K Buy
2,671
+2
+0.1% +$324 0.36% 34
2020
Q4
$420K Buy
+2,669
New +$394K 0.38% 33

Other funds holding JNJ

Freedman Financial Associates's JNJ Position: Q2 2022 in Review

Freedman Financial Associates sold out of Johnson & Johnson (JNJ) in Q2 2022, closing a stake of 2,751 shares — an estimated $485K sold.

Freedman Financial Associates first reported a position in JNJ in Q4 2020 and held it in 6 quarters. The position peaked at $485K in Q1 2022. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • Freedman Financial Associates reported no remaining Johnson & Johnson position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 2,751 Johnson & Johnson shares in Q2 2022, an estimated $485K.
  • Freedman Financial Associates first reported a position in Johnson & Johnson in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Johnson & Johnson position peaked at $485K in Q1 2022.
  • 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.